title: Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.
authors.forename: Oliver A
authors.initials: OA
authors.lastname: Cornely
authors.forename: Rafael F
authors.initials: RF
authors.lastname: Duarte
authors.forename: Shariq
authors.initials: S
authors.lastname: Haider
authors.forename: Pranatharthi
authors.initials: P
authors.lastname: Chandrasekar
authors.forename: David
authors.initials: D
authors.lastname: Helfgott
authors.forename: Javier López
authors.initials: JL
authors.lastname: Jiménez
authors.forename: Anna
authors.initials: A
authors.lastname: Candoni
authors.forename: Issam
authors.initials: I
authors.lastname: Raad
authors.forename: Michel
authors.initials: M
authors.lastname: Laverdiere
authors.forename: Amelia
authors.initials: A
authors.lastname: Langston
authors.forename: Nicholas
authors.initials: N
authors.lastname: Kartsonis
authors.forename: Marlou
authors.initials: M
authors.lastname: Van Iersel
authors.forename: Nancy
authors.initials: N
authors.lastname: Connelly
authors.forename: Hetty
authors.initials: H
authors.lastname: Waskin